Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model-Reference-Cited by-同舟云学术

Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model

Published:2002-09 Issue:3 Volume:20 Page:201-205
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Portnoy Yury A,Vostrov Sergey N,Lubenko Irene Yu,Zinner Stephen H,Firsov Alexander A

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model;Firsov;Antimicrob. Agents Chemother.,1991

2. Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in vitro dynamic model;Firsov;J. Antimicrob. Chemother.,1999

3. Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio;Vostrov;Antimicrob. Agents Chemother.,2000

4. Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses;Firsov;J. Antimicrob. Chemother.,2000

5. Gemifloxacin and ciprofloxacin pharmacodynamics in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses;Firsov;Int. J. Antimicrob. Agents,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemifloxacin for the Treatment of Respiratory Tract Infections: In Vitro Susceptibility, Pharmacokinetics and Pharmacodynamics, Clinical Efficacy, and Safety;Pharmacotherapy;2005-05

2. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae;Journal of Antimicrobial Chemotherapy;2004-01-16